SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-093263
Filing Date
2024-04-11
Accepted
2024-04-11 16:21:27
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d688560ddefa14a.htm DEFA14A 21758
2 GRAPHIC g688560dsp004.jpg GRAPHIC 15695
3 GRAPHIC g688560dsp004a.jpg GRAPHIC 13085
4 GRAPHIC g688560dsp004b.jpg GRAPHIC 1543
5 GRAPHIC g688560dsp004c.jpg GRAPHIC 1381
6 GRAPHIC g688560dsp004d.jpg GRAPHIC 1339
7 GRAPHIC g688560dsp005.jpg GRAPHIC 2475
8 GRAPHIC g688560dsp3d.jpg GRAPHIC 4880
9 GRAPHIC g688560dsp3ejpg.jpg GRAPHIC 5604
  Complete submission text file 0001193125-24-093263.txt   87363
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40128 | Film No.: 24838776
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)